J Urol Oncol.
2023 Jul;21(2):106-111. 10.22465/juo.234600320016.
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
- Affiliations
-
- 1Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- KMID: 2544860
- DOI: http://doi.org/10.22465/juo.234600320016
Abstract
- The Prostate Imaging and Reporting and Data System version 2.1 (PI-RADSv2.1) is commonly utilized in interpreting magnetic resonance imaging (MRI) scans in men with elevated prostate-specific antigen levels. This system aids in the risk stratification of prostate cancer and facilitates communication between radiologists and urologists. However, the current PI-RADSv2.1 decision rules present several pitfalls, particularly in relation to definitions, categorizations, MRI sequences, MRI protocols, and MRI interpretations. There are few reports addressing these limitations. The aim of this review is to outline the pitfalls encountered when applying PI-RADSv2.1.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection
- Prostate Imaging Reporting and Data System (PI-RADS) v 2.1: Overview and Critical Points
- Automated Reporting System Using Structured Data Entry: Application to Prostate US
- Role of Magnetic Resonance Imaging Using Prostate Imaging-Reporting and Data System Version 2 to Predict Clinically Significant Cancer After Radical Prostatectomy in Very Low-Risk or Low-Risk Prostate Cancer
- Breast Imaging Reporting and Data System (BI-RADS): Advantages and Limitations
